Tecfidera hosrse banner
Tecfidera hosrse banner

TECFIDERA is the Preferred Oral Option Among
Healthcare Providers1,2

The #1 prescribed oral RMS therapy in the US since September 20133*
The #1 prescribed oral RMS therapy in the US since September 20133*
>425K patients treated with TECFIDERA worldwide
>425K patients treated with TECFIDERA worldwide

Patients around the world have been treated with TECFIDERA

This includes clinical trial use and patients prescribed TECFIDERA

>810K global patient-years of experience with TECFIDERA
>810K global patient-years of experience with TECFIDERA

Global patient-years of experience with TECFIDERA

This includes clinical trial use and patients prescribed TECFIDERA

>10 years of combined clinical trial and real-world experience
>10 years of combined clinical trial and real-world experience

of combined clinical trial and real-world experience

 

*As of December 27, 2019. Based on prescriptions since September 27, 2013.